| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Jun 1, 2023 | Niagen Bioscience, Inc. | CEO | Buy | 60.0 | +7,000 | 0.44% | ✗ | $9.9K |
| Sep 30, 2022 | Oct 3, 2022 | Niagen Bioscience, Inc. | Cheif Executive Officer | Buy | 90.0 | +80,000 | 5.36% | ✗ | $100K |
| Mar 16, 2022 | Mar 16, 2022 | Niagen Bioscience, Inc. | CEO | Buy | 82.5 | +25,000 | 1.70% | ✗ | $54K |
| May 13, 2021 | May 17, 2021 | Niagen Bioscience, Inc. | CEO | Buy | 72.5 | +10,000 | 0.69% | ✗ | $66.5K |
| May 19, 2020 | May 19, 2020 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +1,000 | 0.07% | ✗ | $4.7K |
| Nov 14, 2019 | Nov 15, 2019 | Niagen Bioscience, Inc. | CEO | Buy | 68.8 | +10,000 | 0.69% | ✗ | $30.9K |
| Aug 23, 2019 | Aug 26, 2019 | Niagen Bioscience, Inc. | CEO | Buy | 56.3 | +2,500 | 0.17% | ✗ | $10.1K |
| May 21, 2019 | May 22, 2019 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +2,253 | 0.16% | ✗ | $10K |
| Mar 13, 2019 | Mar 15, 2019 | Niagen Bioscience, Inc. | CEO | Buy | 91.3 | +171,666 | 13.49% | ✗ | $19K |
| May 15, 2018 | May 16, 2018 | Niagen Bioscience, Inc. | COO | Buy | 78.8 | +10,000 | 1.08% | ✗ | $36.3K |
| Aug 15, 2017 | Aug 16, 2017 | Niagen Bioscience, Inc. | President | Buy | 78.8 | +10,000 | 1.71% | ✗ | $31.5K |
| Nov 7, 2016 | Nov 8, 2016 | Fluent, Inc. | Director | Buy | 67.5 | +2,000 | 0.60% | ✗ | $7.5K |
| Sep 1, 2016 | Sep 6, 2016 | Niagen Bioscience, Inc. | Director | Buy | 95.0 | +15,000 | 23.18% | ✗ | $50.9K |
| Jan 29, 2016 | Feb 16, 2016 | Niagen Bioscience, Inc. | Director | Sell | 27.5 | -5,063 | -2.54% | ✗ | $6.4K |